Evidence map›Paper›PMID 23650617›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2013

Group V secretory phospholipase A2 is involved in macrophage activation and is sufficient for macrophage effector functions in allergic pulmonary inflammation.

Shin Ohta, Mitsuru Imamura, Wei Xing, Joshua A Boyce, Barbara Balestrieri

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Regulatory Roles of Phospholipase AFrontiers in immunology · 2022
    Review
  5. Article
  6. Updating Phospholipase ABiomolecules · 2020
    Review
  7. The Intricate Web of Phospholipase AAmerican journal of respiratory cell and molecular biology · 2020
    Article
  8. Group V secreted phospholipase AThe Journal of biological chemistry · 2020
    Article
  9. Harmful and protective roles of group V phospholipase ABiochimica et biophysica acta. Molecular and cell biology of lipids · 2019
    Review
  10. Function of secreted phospholipase ABiochimica et biophysica acta. Molecular and cell biology of lipids · 2019
    Review
  11. Article
  12. Review
  13. Article
  14. Lipoquality control by phospholipase AProceedings of the Japan Academy. Series B, Physical and biological sciences · 2017
    Review
  15. Identification of Epithelial Phospholipase AAmerican journal of respiratory cell and molecular biology · 2016
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Metabolic regulation by secreted phospholipase AInflammation and regeneration · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Shin OhtaDepartment of Medicine, Harvard Medical School, Boston, MA 02115, USA.
Mitsuru Imamura
Wei Xing
Joshua A Boyce
Barbara Balestrieri
Brigham and Women's Hospital · USHarvard University · US

Funding

Therapeutic Control of Aspirin-Exacerbated Respiratory DiseaseU19AI095219 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI Nora Amanda Barrett · 2011 to 2026
$29.1M
Role of PGE2 in Human Mast Cell BiologyP01HL036110 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI BEIER, DAVID R. · 1985 to 2009
$20.1M
IMMUNOLOGIC BASIS OF RESISTANCE AND HYPERSENSITIVITYT32AI007306 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI Nora Amanda Barrett, Joshua A Boyce · 1985 to 2026
$12.2M
Regulation of Pulmonary Prostaglandins by Leukotriene E4R01AI078908 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI BOYCE, JOSHUA A · 2009 to 2025
$8.8M
Role of Integrin alphaEbeta7 on Th2 Immune ResponsesP01AI031599 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI AUSTEN, KARL FRANK · 1999 to 2007
$7.7M
CysLT and P2Y Receptors in Lung InflammationR37AI052353 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI BOYCE, JOSHUA A · 2013 to 2022
$5.2M
CystLT and P2Y Receptors and Lung InflammationR01AI052353 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI BOYCE, JOSHUA A · 2002 to 2012
$4.2M
Group V sPLA2 in alternative activation of macrophages and pulmonary inflammationR01HL113071 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI BALESTRIERI, BARBARA · 2013 to 2017
$1.9M
Eicosanoid Networks in Aspirin Exacerbated Respiratory DiseaseR01HL117945 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI BOYCE, JOSHUA A · 2013 to 2016
$1.5M
Group V sPla2 in Inflammation and Innate ImmunityK08AI064226 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI BALESTRIERI, BARBARA · 2007 to 2011
$651k
CysLt and P2Y Receptors and Lung InflammationR56AI052353 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI BOYCE, JOSHUA A · 2007 to 2007
$419k
Group VsPLA2 in Innate Immunity and Pulmonary InflammationR56HL113071 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI BALESTRIERI, BARBARA · 2019 to 2019
$400k
NHLBI NIH HHS HL113071NHLBI NIH HHS HL36110NHLBI NIH HHS P01 HL036110NHLBI NIH HHS R01 HL113071NHLBI NIH HHS R01 HL117945NHLBI NIH HHS R56 HL113071NIAID NIH HHS AI064226NIAID NIH HHS AI07306NIAID NIH HHS AI31599NIAID NIH HHS AI52353NIAID NIH HHS K08 AI064226NIAID NIH HHS P01 AI031599NIAID NIH HHS R01 AI052353NIAID NIH HHS R01 AI078908NIAID NIH HHS R37 AI052353NIAID NIH HHS R56 AI052353NIAID NIH HHS T32 AI007306NIAID NIH HHS U19 AI031599NIAID NIH HHS U19 AI095219
6 · The paper itself

Abstract

We reported that Pla2g5-null mice lacking group V secretory phospholipase A2 (gV-sPLA2) showed reduced eosinophilic pulmonary inflammation and Th2 cytokine generation when challenged with an extract from house dust mite Dermatophagoides farinae, compared with wild-type (WT) controls. Adoptive transfer studies suggested that gV-sPLA2 in dendritic cells was necessary for sensitization of Pla2g5-null mice, but was not sufficient to induce the effector phase of pulmonary inflammation. In this study, we demonstrate that gV-sPLA2 is inducibly expressed in mouse and human macrophages (M) activated by IL-4 and is required for the acquisition of M effector functions that facilitate the effector phase of pulmonary inflammation. We demonstrate that gV-sPLA2 expression in M is sufficient for the development of pulmonary inflammation, even when inflammation is induced by intrapulmonary administration of IL-4. The concentrations of CCL22/CCL17 and effector T cell recruitment are severely impaired in Pla2g5-null mice. Intratracheal transfers of enriched CD68(+) cells isolated from the lungs of D. farinae-challenged WT donor mice induce eosinophilia, chemokine production, and recruitment of T cells into the lungs of Pla2g5-null recipients previously sensitized by WT D. farinae-loaded dendritic cells. Our studies identified a unique function of gV-sPLA2 in activation of M and in their capacity to recruit T cells to amplify the effector phase of pulmonary inflammation.

Indexed as

AnimalsFluorescent Antibody TechniqueGroup V Phospholipases A2HumansHypersensitivityImmunohistochemistryLymphocyte ActivationMacrophage ActivationMacrophagesMiceMice, Inbred C57BLMice, KnockoutPneumoniaT-LymphocytesGroup V Phospholipases A2

Identifiers

PMID23650617
PMCPMC3939699
OpenAlexW1891081281

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.